Surrogate endpoints in second-line treatment for mCRC: A systematic literature-based analysis from 23 randomised trials
暂无分享,去创建一个
D. Ankerst | U. Mansmann | V. Heinemann | R. Laubender | S. Stintzing | D. Modest | C. Giessen | C. Schulz
暂无分享,去创建一个
D. Ankerst | U. Mansmann | V. Heinemann | R. Laubender | S. Stintzing | D. Modest | C. Giessen | C. Schulz